Literature DB >> 15220212

Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.

Stephen S Rich1, Donald W Bowden, Steven M Haffner, Jill M Norris, Mohammed F Saad, Braxton D Mitchell, Jerome I Rotter, Carl D Langefeld, Lynne E Wagenknecht, Richard N Bergman.   

Abstract

Genetic and environmental determinants play critical roles in insulin resistance and beta-cell function. A model of the complex feedback system for maintenance of glucose tolerance has been developed that reflects the constraint of glycemia within narrow physiologic limits. The "glucose homeostasis" model is described by insulin sensitivity (S(I)), glucose disposition (S(G)), acute insulin response to glucose (AIR(G)), and disposition index (DI). Relatively little is known about the genetic basis of glucose homeostasis phenotypes or their relationship to risk of diabetes and atherosclerotic cardiovascular disease. A genome scan for glucose homeostasis phenotypes in nondiabetic subjects has been carried out in African-American (n = 21) and Hispanic (n = 45) extended families as part of the IRAS Family Study. In African-American families, there was significant evidence for linkage of DI between D11S2371 and D11S2002 (logarithm of odds [LOD] = 3.21) at 81 cM, and in the combined sample of African-American and Hispanic families, there was evidence at GATA117D01 (140 cM) on chromosome 11 (LOD = 2.21). Evidence of linkage was also observed for S(I) in Hispanic (LOD = 2.28, between D15S822 and GTTTT001) and AIR(G) in African-American families (LOD = 2.73, between D4S1625 and D4S1629; and LOD = 2.56 at PAH (phenylalanine hydroxylase) on chromosome 12). These results provide impetus for future positional cloning of quantitative trait loci (QTLs). Identifying genes in these regions should provide insight into the nature of the metabolic syndrome and diabetes, and facilitate the development of more effective therapies for prevention and treatment of diabetes and other diseases associated with disordered glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220212     DOI: 10.2337/diabetes.53.7.1866

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  28 in total

Review 1.  Genetic epidemiology of diabetes.

Authors:  M Alan Permutt; Jonathon Wasson; Nancy Cox
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

2.  Functional mapping of disease susceptibility loci using cell biology.

Authors:  Peter A Antinozzi; Alejandro Garcia-Diaz; Chuan Hu; James E Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

3.  Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans.

Authors:  V Saroja Voruganti; Juan C Lopez-Alvarenga; Subrata D Nath; David L Rainwater; Richard Bauer; Shelley A Cole; Jean W Maccluer; John Blangero; Anthony G Comuzzie
Journal:  J Mol Med (Berl)       Date:  2008-01-17       Impact factor: 4.599

4.  Agreement among type 2 diabetes linkage studies but a poor correlation with results from genome-wide association studies.

Authors:  S Lillioja; A Wilton
Journal:  Diabetologia       Date:  2009-03-19       Impact factor: 10.122

Review 5.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

6.  Hostility and minimal model of glucose kinetics in African American women.

Authors:  Richard S Surwit; James D Lane; David S Millington; Haoyue Zhang; Mark N Feinglos; Sharon Minda; Rhonda Merwin; Cynthia M Kuhn; Raymond C Boston; Anastasia Georgiades
Journal:  Psychosom Med       Date:  2009-06-26       Impact factor: 4.312

7.  Bivariate genome-wide scan for metabolic phenotypes in non-diabetic Chinese individuals from the Stanford, Asia and Pacific Program of Hypertension and Insulin Resistance Family Study.

Authors:  Y-F Chiu; L-M Chuang; H-Y Kao; L-T Ho; C-T Ting; Y-J Hung; Y-D Chen; T Donlon; J D Curb; T Quertermous; C A Hsiung
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

8.  Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study.

Authors:  N D Palmer; C D Langefeld; J T Ziegler; F Hsu; S M Haffner; T Fingerlin; J M Norris; Y I Chen; S S Rich; T Haritunians; K D Taylor; R N Bergman; J I Rotter; D W Bowden
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

9.  Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS Family Study.

Authors:  Nicholette D Palmer; Josyf C Mychaleckyj; Carl D Langefeld; Julie T Ziegler; Adrienne H Williams; Michael Bryer-Ash; Donald W Bowden
Journal:  Diabetes Res Clin Pract       Date:  2009-11-20       Impact factor: 5.602

Review 10.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.